COPD patients with emphysema generally show neutrophil-based inflammation with elevated levels of neutrophil chemoattractants such as CXCL8, MPO, and LTB4, which promotes persistence of neutrophils in the airways of these patients [58]. Here, MPO is linked to chronic obstructive pulmonary disease.